Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly diagnosed multiple myeloma. 2011

Philippe Moreau, and Herve Avet-Loiseau, and Thierry Facon, and Michel Attal, and Mourad Tiab, and Cyrille Hulin, and Chantal Doyen, and Laurent Garderet, and Edouard Randriamalala, and Carla Araujo, and Gérard Lepeu, and Gerald Marit, and Denis Caillot, and Martine Escoffre, and Bruno Lioure, and Lotfi Benboubker, and Brigitte Pégourié, and Brigitte Kolb, and Anne Marie Stoppa, and Jean-Gabriel Fuzibet, and Olivier Decaux, and Mamoun Dib, and Christian Berthou, and Carine Chaleteix, and Catherine Sebban, and Catherine Traullé, and Jean Fontan, and Marc Wetterwald, and Pascal Lenain, and Claire Mathiot, and Jean-Luc Harousseau
University Hospital, Nantes, France.

The Intergroupe Francophone du Myelome conducted a randomized trial to compare bortezomib-dexamethasone (VD) as induction before high-dose therapy (HDT) and autologous stem cell transplantation (ASCT) to a combination consisting of reduced doses of bortezomib and thalidomide plus dexamethasone (vtD) in patients with multiple myeloma. Overall, a total of 199 patients were centrally randomly assigned to receive VD or vtD. After 4 cycles, the complete response (CR) rate was the same in both groups (13% in the vtD arm, 12% in the VD arm, P = .74). However, the CR plus very good partial response (VGPR) rate was significantly higher in the vtD arm (49% vs 36%, P = .05). After ASCT, the CR plus VGPR rate was significantly higher in the vtD arm (74% vs 58%, P = .02). The reduced doses of bortezomib and thalidomide translated into a reduced incidence of peripheral neuropathy (PN): grade ≥ 2 PN were reported in 34% in the VD arm versus 14% in the vtD arm (P = .001). vtD, including reduced doses of bortezomib and thalidomide, yields higher VGPR rates compared with VD and can be considered a new effective triplet combination before HDT/ASCT.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D011719 Pyrazines A heterocyclic aromatic organic compound with the chemical formula C4H4N2. Pyrazine
D001897 Boronic Acids Inorganic or organic compounds that contain the basic structure RB(OH)2. Boronic Acid,Acid, Boronic,Acids, Boronic
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Philippe Moreau, and Herve Avet-Loiseau, and Thierry Facon, and Michel Attal, and Mourad Tiab, and Cyrille Hulin, and Chantal Doyen, and Laurent Garderet, and Edouard Randriamalala, and Carla Araujo, and Gérard Lepeu, and Gerald Marit, and Denis Caillot, and Martine Escoffre, and Bruno Lioure, and Lotfi Benboubker, and Brigitte Pégourié, and Brigitte Kolb, and Anne Marie Stoppa, and Jean-Gabriel Fuzibet, and Olivier Decaux, and Mamoun Dib, and Christian Berthou, and Carine Chaleteix, and Catherine Sebban, and Catherine Traullé, and Jean Fontan, and Marc Wetterwald, and Pascal Lenain, and Claire Mathiot, and Jean-Luc Harousseau
February 2015, British journal of haematology,
Philippe Moreau, and Herve Avet-Loiseau, and Thierry Facon, and Michel Attal, and Mourad Tiab, and Cyrille Hulin, and Chantal Doyen, and Laurent Garderet, and Edouard Randriamalala, and Carla Araujo, and Gérard Lepeu, and Gerald Marit, and Denis Caillot, and Martine Escoffre, and Bruno Lioure, and Lotfi Benboubker, and Brigitte Pégourié, and Brigitte Kolb, and Anne Marie Stoppa, and Jean-Gabriel Fuzibet, and Olivier Decaux, and Mamoun Dib, and Christian Berthou, and Carine Chaleteix, and Catherine Sebban, and Catherine Traullé, and Jean Fontan, and Marc Wetterwald, and Pascal Lenain, and Claire Mathiot, and Jean-Luc Harousseau
December 2010, Lancet (London, England),
Philippe Moreau, and Herve Avet-Loiseau, and Thierry Facon, and Michel Attal, and Mourad Tiab, and Cyrille Hulin, and Chantal Doyen, and Laurent Garderet, and Edouard Randriamalala, and Carla Araujo, and Gérard Lepeu, and Gerald Marit, and Denis Caillot, and Martine Escoffre, and Bruno Lioure, and Lotfi Benboubker, and Brigitte Pégourié, and Brigitte Kolb, and Anne Marie Stoppa, and Jean-Gabriel Fuzibet, and Olivier Decaux, and Mamoun Dib, and Christian Berthou, and Carine Chaleteix, and Catherine Sebban, and Catherine Traullé, and Jean Fontan, and Marc Wetterwald, and Pascal Lenain, and Claire Mathiot, and Jean-Luc Harousseau
October 2023, Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie,
Philippe Moreau, and Herve Avet-Loiseau, and Thierry Facon, and Michel Attal, and Mourad Tiab, and Cyrille Hulin, and Chantal Doyen, and Laurent Garderet, and Edouard Randriamalala, and Carla Araujo, and Gérard Lepeu, and Gerald Marit, and Denis Caillot, and Martine Escoffre, and Bruno Lioure, and Lotfi Benboubker, and Brigitte Pégourié, and Brigitte Kolb, and Anne Marie Stoppa, and Jean-Gabriel Fuzibet, and Olivier Decaux, and Mamoun Dib, and Christian Berthou, and Carine Chaleteix, and Catherine Sebban, and Catherine Traullé, and Jean Fontan, and Marc Wetterwald, and Pascal Lenain, and Claire Mathiot, and Jean-Luc Harousseau
August 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,
Philippe Moreau, and Herve Avet-Loiseau, and Thierry Facon, and Michel Attal, and Mourad Tiab, and Cyrille Hulin, and Chantal Doyen, and Laurent Garderet, and Edouard Randriamalala, and Carla Araujo, and Gérard Lepeu, and Gerald Marit, and Denis Caillot, and Martine Escoffre, and Bruno Lioure, and Lotfi Benboubker, and Brigitte Pégourié, and Brigitte Kolb, and Anne Marie Stoppa, and Jean-Gabriel Fuzibet, and Olivier Decaux, and Mamoun Dib, and Christian Berthou, and Carine Chaleteix, and Catherine Sebban, and Catherine Traullé, and Jean Fontan, and Marc Wetterwald, and Pascal Lenain, and Claire Mathiot, and Jean-Luc Harousseau
July 2012, Blood,
Philippe Moreau, and Herve Avet-Loiseau, and Thierry Facon, and Michel Attal, and Mourad Tiab, and Cyrille Hulin, and Chantal Doyen, and Laurent Garderet, and Edouard Randriamalala, and Carla Araujo, and Gérard Lepeu, and Gerald Marit, and Denis Caillot, and Martine Escoffre, and Bruno Lioure, and Lotfi Benboubker, and Brigitte Pégourié, and Brigitte Kolb, and Anne Marie Stoppa, and Jean-Gabriel Fuzibet, and Olivier Decaux, and Mamoun Dib, and Christian Berthou, and Carine Chaleteix, and Catherine Sebban, and Catherine Traullé, and Jean Fontan, and Marc Wetterwald, and Pascal Lenain, and Claire Mathiot, and Jean-Luc Harousseau
February 2013, British journal of haematology,
Philippe Moreau, and Herve Avet-Loiseau, and Thierry Facon, and Michel Attal, and Mourad Tiab, and Cyrille Hulin, and Chantal Doyen, and Laurent Garderet, and Edouard Randriamalala, and Carla Araujo, and Gérard Lepeu, and Gerald Marit, and Denis Caillot, and Martine Escoffre, and Bruno Lioure, and Lotfi Benboubker, and Brigitte Pégourié, and Brigitte Kolb, and Anne Marie Stoppa, and Jean-Gabriel Fuzibet, and Olivier Decaux, and Mamoun Dib, and Christian Berthou, and Carine Chaleteix, and Catherine Sebban, and Catherine Traullé, and Jean Fontan, and Marc Wetterwald, and Pascal Lenain, and Claire Mathiot, and Jean-Luc Harousseau
October 2010, Annals of hematology,
Philippe Moreau, and Herve Avet-Loiseau, and Thierry Facon, and Michel Attal, and Mourad Tiab, and Cyrille Hulin, and Chantal Doyen, and Laurent Garderet, and Edouard Randriamalala, and Carla Araujo, and Gérard Lepeu, and Gerald Marit, and Denis Caillot, and Martine Escoffre, and Bruno Lioure, and Lotfi Benboubker, and Brigitte Pégourié, and Brigitte Kolb, and Anne Marie Stoppa, and Jean-Gabriel Fuzibet, and Olivier Decaux, and Mamoun Dib, and Christian Berthou, and Carine Chaleteix, and Catherine Sebban, and Catherine Traullé, and Jean Fontan, and Marc Wetterwald, and Pascal Lenain, and Claire Mathiot, and Jean-Luc Harousseau
December 2015, Leukemia,
Philippe Moreau, and Herve Avet-Loiseau, and Thierry Facon, and Michel Attal, and Mourad Tiab, and Cyrille Hulin, and Chantal Doyen, and Laurent Garderet, and Edouard Randriamalala, and Carla Araujo, and Gérard Lepeu, and Gerald Marit, and Denis Caillot, and Martine Escoffre, and Bruno Lioure, and Lotfi Benboubker, and Brigitte Pégourié, and Brigitte Kolb, and Anne Marie Stoppa, and Jean-Gabriel Fuzibet, and Olivier Decaux, and Mamoun Dib, and Christian Berthou, and Carine Chaleteix, and Catherine Sebban, and Catherine Traullé, and Jean Fontan, and Marc Wetterwald, and Pascal Lenain, and Claire Mathiot, and Jean-Luc Harousseau
October 2010, Anatomical record (Hoboken, N.J. : 2007),
Philippe Moreau, and Herve Avet-Loiseau, and Thierry Facon, and Michel Attal, and Mourad Tiab, and Cyrille Hulin, and Chantal Doyen, and Laurent Garderet, and Edouard Randriamalala, and Carla Araujo, and Gérard Lepeu, and Gerald Marit, and Denis Caillot, and Martine Escoffre, and Bruno Lioure, and Lotfi Benboubker, and Brigitte Pégourié, and Brigitte Kolb, and Anne Marie Stoppa, and Jean-Gabriel Fuzibet, and Olivier Decaux, and Mamoun Dib, and Christian Berthou, and Carine Chaleteix, and Catherine Sebban, and Catherine Traullé, and Jean Fontan, and Marc Wetterwald, and Pascal Lenain, and Claire Mathiot, and Jean-Luc Harousseau
March 2011, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Copied contents to your clipboard!